Global Industries Healthcare Division Receives FDA Approval for Innovative Medical Device

NEW YORK, NY -- Global Industries Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved GlucoWatch, the company's innovative non-invasive continuous glucose monitoring device.

GlucoWatch uses advanced optical sensors to measure blood glucose levels through the skin, eliminating the need for finger pricks or invasive sensors.

"This approval represents a major breakthrough for the millions of people living with diabetes," said Dr. Jennifer Lee, President of Global Industries Healthcare. "GlucoWatch will transform how patients manage their condition."